Prenatal Exercise and Glucose Regulation
for Gestational Diabetes Mellitus
1 location in Conway
Sponsor: University of Central Arkansas
Sex: Female·Age: 18 - 35·Accepts healthy volunteers
Code: NCT07802262·Recruiting·Listed Sep 3, 2026
Paid Clinical Trials in Arkansas
Arkansas has 701 paid clinical trials enrolling now across cities including Little Rock, Jonesboro and Springdale. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Arkansas include National Cancer Institute (NCI), University of Arkansas and Arkansas Children's Hospital Research Institute, running studies across oncology, cardiology, neurology, and more. The most actively recruiting conditions are Schizophrenia, Acute Myeloid Leukemia, Major Depressive Disorder, Duchenne Muscular Dystrophy — browse the full list or use the filters to match your diagnosis. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Arkansas
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
for Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Drug: Pemvidutide
Sites in North Little Rock +8 more locations
Sponsor: Altimmune, Inc.
Sex: All·Age: 18 - 75
Code: NCT07795164·Phase 3·Recruiting·Listed Aug 31, 2026
Detection of Atrial Fibrillation Using PPG From Smartphone Cameras
for Atrial Fibrillation (AF)
Sites in Jonesboro +3 more locations
Sponsor: Happitech BV
Sex: All·Age: 22 Minutes+
Code: NCT07779213·Recruiting·Listed Aug 21, 2026
Non-invasive Prediction of EArly Cardiac rEjection
for Heart Transplant
Sites in Little Rock +21 more locations
Sponsor: Vanderbilt University Medical Center
Sex: All·Age: 6 - 25
Code: NCT07770659·Recruiting·Listed Aug 18, 2026
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
for IgE-Mediated Food Allergy
Drug: Remibrutinib
Sites in Little Rock +7 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 12 - 65
Code: NCT07768371·Phase 3·Recruiting·Listed Aug 17, 2026
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
for Smoking Cessation
Sites in Little Rock +15 more locations
Sponsor: Axsome Therapeutics, Inc.
Sex: All·Age: 18 - 65
Code: NCT07766655·Phase 3·Recruiting·Listed Aug 14, 2026
640 clinical trials
Get a weekly email when new trials open in Little Rock, AR.
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for Migraine
Drug: Elismetrep
Sites in Little Rock +112 more locations
Sponsor: Kallyope Inc.
Sex: All·Age: 18 - 75
Code: NCT07645924·Phase 3·Recruiting·Listed Jun 2026
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
for Pneumococcal Disease
Sites in Jonesboro, Fayetteville +104 more locations
Sponsor: Pfizer
Sex: All·Age: 42 Days - 211 Days·Accepts healthy volunteers
Code: NCT07629440·Phase 3·Recruiting·Listed Jun 2026
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
for Obesity
Drug: NNC0487-0111
Sites in Little Rock +205 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07567001·Phase 3·Recruiting·Listed May 2026
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
for Atopic Dermatitis
Sites in Bryant +32 more locations
Sponsor: Apollo Therapeutics Ltd
Sex: All·Age: 18 - 65
Code: NCT07599813·Phase 2·Recruiting·Listed May 2026
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
for Major Depressive Disorder
Sites in Little Rock +29 more locations
Sponsor: Definium Therapeutics US, Inc.
Sex: All·Age: 18 - 74
Code: NCT07592689·Phase 3·Recruiting·Listed May 2026
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for Cardiovascular Disease and Lipoprotein(a)
Drug: Pelacarsen
Sites in Little Rock +100 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT07517263·Phase 3·Recruiting·Listed Apr 2026
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
for Bipolar I Disorder
Sites in Little Rock, Bentonville +24 more locations
Sponsor: LB Pharmaceuticals Inc.
Sex: All·Age: 18 - 65
Code: NCT07494305·Phase 2·Recruiting·Listed Mar 2026
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
for Urothelial Cancer
Drug: PF-08634404
Sites in Springdale, Fayetteville +131 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07421700·Phase 1, Phase 2·Recruiting·Listed Feb 2026
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
for Macular Degeneration
Sites in Springdale, Fayetteville +62 more locations
Sponsor: EyeBiotech Ltd.
Sex: All·Age: 50+
Code: NCT07440225·Phase 2, Phase 3·Recruiting·Listed Feb 2026
A Study of Brenipatide in Adult Participants With Schizophrenia
for Schizophrenia
Drug: Brenipatide
Sites in Little Rock +31 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 55
Code: NCT07410507·Phase 2·Recruiting·Listed Feb 2026
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for Parkinson Disease
Sites in Little Rock +29 more locations
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All·Age: 30 - 80
Code: NCT07432958·Phase 2·Recruiting·Listed Feb 2026
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
for MASH - Metabolic Dysfunction-Associated Steatohepatitis
Sites in Little Rock +30 more locations
Sponsor: Rivus Pharmaceuticals, Inc.
Sex: All·Age: 30+
Code: NCT07491458·Phase 2·Recruiting·Listed Mar 2026
A Study of Brenipatide in Participants With Opioid Use Disorder
for Opioid Use Disorder
Drug: Brenipatide
Sites in Little Rock +37 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07420283·Phase 2·Recruiting·Listed Feb 2026
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for Pancreatic Cancer
Sites in Fort Smith +48 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT07409272·Phase 3·Recruiting·Listed Feb 2026
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
for Post Traumatic Stress Disorder
Drug: TSND-201
Sites in Little Rock +31 more locations
Sponsor: Transcend Therapeutics
Sex: All·Age: 18+
Code: NCT07456696·Phase 3·Recruiting·Listed Mar 2026
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
for Neovascular Age-Related Macular Degeneration (nAMD)
Drug: Ixo-vec
Sites in Springdale +78 more locations
Sponsor: Adverum Biotechnologies, Inc.
Sex: All·Age: 50+
Code: NCT07482176·Phase 3·Recruiting·Listed Mar 2026
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for Chronic Idiopathic Constipation (CIC)
Drug: Tenapanor
Sites in North Little Rock +108 more locations
Sponsor: Ardelyx
Sex: All·Age: 18 - 80
Code: NCT07382167·Phase 3·Recruiting·Listed Feb 2026
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for Clostridoides Difficile Associated Disease
Sites in Little Rock +139 more locations
Sponsor: Pfizer
Sex: All·Age: 65+·Accepts healthy volunteers
Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
for Metabolic Dysfunction-associated Steatohepatitis
Sites in Little Rock +62 more locations
Sponsor: Eccogene
Sex: All·Age: 18 - 75
Code: NCT07288138·Phase 2·Recruiting·Listed Dec 2025
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
for Schizophrenia
Drug: KarXT
Sites in Bryant +54 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07379827·Recruiting·Listed Feb 2026
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
for Advanced Non-Small Cell Lung Cancer
Drug: PF-08634404
Sites in Springdale, Fayetteville +204 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
for Ventricular Arrythmia
Sites in Jonesboro +26 more locations
Sponsor: AtaCor Medical, Inc.
Sex: All·Age: 18+
Code: NCT07324031·Recruiting·Listed Jan 2026
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for Intestinal Neoplasms
Drug: PF-08634404
Sites in Springdale, Fayetteville +198 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07222800·Phase 3·Recruiting·Listed Oct 2025
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
for Diabetic Kidney Disease (DKD)
Drug: ALN-ANG3
Sites in Little Rock +57 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18 - 80
Code: NCT07271186·Phase 2·Recruiting·Listed Dec 2025
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
for Carcinoma, Renal Cell
Drug: PF-08634404
Sites in Springdale, Fayetteville +107 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for Diabetic Peripheral Neuropathic Pain
Sites in Little Rock +69 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 18 - 80
Code: NCT07231419·Phase 3·Recruiting·Listed Nov 2025
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for Non-small Cell Carcinoma
Sites in Springdale, Fayetteville +221 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for Prostatic Neoplasms, Castration-Resistant
Drug: Pasritamig
Sites in Little Rock +52 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07225946·Phase 3·Recruiting·Listed Nov 2025
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
for Advanced/Metastatic Non-Small Cell Lung Cancer
Drug: PF-08634404
Sites in Springdale, Fayetteville +42 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07227298·Phase 1, Phase 2·Recruiting·Listed Nov 2025
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
for Metabolic Dysfunction-Associated Steatotic Liver Disease
Sites in North Little Rock +141 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07165028·Phase 3·Recruiting·Listed Sep 2025
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for Untreated, Unresectable, or Metastatic Colorectal Cancer
Drug: Bevacizumab
Sites in Springdale +43 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221357·Phase 2, Phase 3·Recruiting·Listed Oct 2025
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Little Rock +38 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
Sites in Little Rock +63 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for Breast Neoplasms
Sites in Springdale, Hot Springs +124 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
for Alcohol Use Disorder
Drug: Brenipatide
Sites in Little Rock +29 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219966·Phase 3·Recruiting·Listed Oct 2025
A Study of Brenipatide in Participants With Alcohol Use Disorder
for Alcohol Use Disorder
Drug: Brenipatide
Sites in Little Rock +28 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219953·Phase 3·Recruiting·Listed Oct 2025
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for Major Depressive Disorder
Drug: Icalcaprant
Sites in Little Rock +32 more locations
Sponsor: AbbVie
Sex: All·Age: 18 - 65
Code: NCT07276997·Phase 2·Recruiting·Listed Dec 2025
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
Drug: Olpasiran
Sites in Little Rock +193 more locations
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
Drug: Duvakitug
Sites in Little Rock +117 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184996·Phase 3·Recruiting·Listed Sep 2025
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
for Obesity With Diabetes
Sites in Little Rock +58 more locations
Sponsor: Kailera
Sex: All·Age: 18+
Code: NCT07284901·Phase 3·Recruiting·Listed Dec 2025
Common conditions studied in Arkansas
- Schizophrenia (20 active studies)
- Acute Myeloid Leukemia (11 active studies)
- Major Depressive Disorder (11 active studies)
- Duchenne Muscular Dystrophy (10 active studies)
- Malignant Solid Neoplasm (9 active studies)
- Obesity (9 active studies)
Leading research sponsors in Arkansas
- National Cancer Institute (NCI)
- University of Arkansas
- Arkansas Children's Hospital Research Institute
- SWOG Cancer Research Network
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Arkansas?
There are approximately 701 recruiting clinical trials in Arkansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Arkansas pay participants?
Most recruiting trials in Arkansas compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Arkansas?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Arkansas?
The most common conditions under active study in Arkansas include Schizophrenia (20), Acute Myeloid Leukemia (11), Major Depressive Disorder (11), Duchenne Muscular Dystrophy (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Arkansas?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Arkansas on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Arkansas?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Browse more clinical trials
All cities in Arkansas
Little Rock, AR(501)Jonesboro, AR(78)Springdale, AR(64)Fayetteville, AR(55)Fort Smith, AR(49)Rogers, AR(49)Hot Springs, AR(21)North Little Rock, AR(20)Bryant, AR(17)Bentonville, AR(11)Conway, AR(4)Arkansas City, AR(3)Searcy, AR(3)Pine Bluff, AR(2)Sherwood, AR(2)West Memphis, AR(2)Batesville, AR(1)Blytheville, AR(1)Corning, AR(1)El Dorado, AR(1)Fairbanks, AR(1)Glenwood, AR(1)Harrisburg, AR(1)Harrison, AR(1)Lavaca, AR(1)Marianna, AR(1)Marshall, AR(1)Monticello, AR(1)Mountain Home, AR(1)Osceola, AR(1)Siloam Springs, AR(1)Texarkana, AR(1)Washington, AR(1)White Hall, AR(1)